Fundraising FoxCrucible Therapeutics
Sheffield, GB · 1 known investors
Find your way into Crucible Therapeutics
Sign up to see every warm intro you have to Crucible Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Crucible Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Crucible develops RNA-based therapies targeting neurodegenerative diseases, leveraging research from the University of Sheffield's translational neuroscience institutes. The company is a biotech spinout dedicated to commercializing innovative therapeutic approaches for patient treatment.
Founders & leadership
CH
Cliff HollowayChief Executive OfficerCliff Holloway previously served as CEO, Chief Business Officer, and director at multiple public and private biotechnology companies, with experience in drug development across various modalities and therapeutic areas, asset partnerships from preclinical through clinical stages, and investor relations.
Investors · 1
Founder mafia
2 people who came through Crucible Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does Crucible Therapeutics do?
- Crucible develops RNA-based therapies targeting neurodegenerative diseases, leveraging research from the University of Sheffield's translational neuroscience institutes. The company is a biotech spinout dedicated to commercializing innovative therapeutic approaches for patient treatment.
- Who are Crucible Therapeutics's investors?
- Crucible Therapeutics's investors include Northern Gritstone.
- Where is Crucible Therapeutics headquartered?
- Crucible Therapeutics is headquartered in Sheffield, GB.